Microvision earnings release, May 13, 2026
Exhibit
99.1
MicroVision
Announces First Quarter 2026 Results
REDMOND,
WA / ACCESSWIRE / May 13, 2026 / MicroVision, Inc. (NASDAQ:MVIS), defining the next generation of lidar-based perception solutions, today announced its first quarter 2026 results.
Key
Business and Operational Highlights
“We feel very good about our accelerating progress throughout the first quarter, establishing a strong foundation and boldly executing on our strategy to transform the lidar industry,” said Glen DeVos, MicroVision’s Chief Executive Officer. “Following the
Q1 asset acquisitions from Luminar and Scantinel, we’ve successfully incorporated the technologies and products, integrated the teams, and streamlined operations. Our broad product portfolio, ready-to-ship sensor inventories, and diversified product roadmap have allowed us to stabilize and strengthen existing commercial relationships while building new opportunities and partnerships.”
“We’ve taken on the challenge of redefining lidar, and it is exciting to see the future taking shape,” concluded DeVos.
Key
Financial Highlights for Q1 2026
Upcoming
Investor Events
Management will participate in the Deutsche Bank Securities Global Autos, Mobility & Robotics Conference, May 19 – 20, 2026 in New York
City.
Conference
Call and Webcast: Q1 2026 Results
MicroVision will host a conference call and webcast, consisting of prepared remarks by management and a question-and-answer session at 1:30 PM PT/4:30
PM ET on Wednesday, May 13, 2026 to discuss the financial results and provide a business update. Analysts and investors may pose questions to management during the live webcast on May 13, 2026.
The live webcast can be accessed on the Company’s Investor Relations website under the Events tab
HERE. The webcast will be archived on the website for future viewing.
About
MicroVision
MicroVision is defining the next generation of lidar-based perception solutions for automotive, industrial, and security & defense markets. As the industry moves beyond proof of concept toward value, deployment, and commercialization, MicroVision delivers integrated hardware and software solutions designed for real-world performance, automotive-grade reliability, and economic scalability. With engineering centers in the U.S. and Germany, MicroVision leads the industry in depth and breadth of its portfolio, with both short- and long-range lidar solutions, featuring solid-state sensors with varying wavelengths, advanced sensor architectures, design-to-cost engineering, and open software solutions.
For more information, visit the Company’s website at www.microvision.com, on Facebook at www.facebook.com/microvisioninc, and LinkedIn at https://www.linkedin.com/company/microvision/.
MicroVision,
MAVIN, MOSAIK, MOVIA, IRIS, and SENTINEL are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.
Non-GAAP information
To supplement MicroVision’s condensed financial statements presented in accordance with GAAP, the Company presents investors with the non-GAAP financial measures “adjusted EBITDA” and “adjusted Gross Profit.” Adjusted EBITDA consists of GAAP net income (loss) excluding the impact of the following: interest income and interest expense; income tax expense; depreciation and amortization; non-cash gains and losses; share-based compensation; restructuring costs; severance expense; and impairment charges. Adjusted Gross Profit is calculated as GAAP gross profit before share-based compensation expense and the amortization of acquired intangibles included in cost of revenue.
MicroVision believes that the presentation of adjusted EBITDA and adjusted Gross Profit provides important supplemental information to management and investors regarding financial and business trends, provides consistency and comparability with MicroVision’s past financial reports, and facilitates comparisons with other companies in the Company’s industry, many of which use similar non-GAAP financial measures to supplement their GAAP results. Internally, management uses these non-GAAP measures when evaluating operating performance because the exclusion of the items described above provides an additional useful measure of the Company’s operating results and facilitates comparisons of the Company’s core operating performance against prior periods and its business objectives. Externally, the Company believes that adjusted EBITDA and adjusted Gross Profit are useful to investors in their assessment of MicroVision’s operating performance and the valuation of the Company.
Adjusted
EBITDA and adjusted Gross Profit are not calculated in accordance with GAAP, and should be considered supplemental to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Non-GAAP financial measures have limitations in that they do not reflect all of the costs associated with the operations of MicroVision’s business as determined in accordance with GAAP.
The Company expects to continue to incur expenses similar to the non-GAAP adjustments described above, and exclusion of these items from its non-GAAP financial measures should not be construed as an inference that these costs are unusual or infrequent.
The
Company compensates for limitations of the adjusted EBITDA measure by prominently disclosing GAAP net income (loss), which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation from GAAP net income (loss) to adjusted
EBITDA.
Similarly for adjusted Gross Profit, the Company compensates for limitations of the measure by prominently disclosing GAAP gross profit which is... (truncated)ding investors with a reconciliation by backing out share-based compensation expense and the amortization of acquired intangibles included in cost of revenue.
Forward-Looking
Statements
Financial statements
Income Statement
Three months ended March 31, — (In thousands, except per share data)
| Three months ended March 31, – 2026 | Three months ended March 31, – 2025 | |
|---|---|---|
| Revenue | 935 | 589 |
| Cost of revenue | 572 | 550 |
| Gross profit | 363 | 39 |
| Research and development expense | 14,445 | 7,403 |
| Sales, marketing, general and administrative expense | 9,511 | 6,676 |
| Impairment loss on operating lease right-of-use assets | 9 | |
| Gain on disposal of fixed assets | -108 | |
| Total operating expenses | 23,857 | 14,079 |
| Loss from operations | -23,494 | -14,040 |
| Interest expense | -2,753 | -12,903 |
| Unrealized gain on derivative liability | 3,380 | 842 |
| Unrealized gain on warrant liability | 604 | 1,761 |
| Realized loss on debt extinguishment | -3,083 | -4,654 |
| Bargain purchase gain | 147 | |
| Other income | 87 | 288 |
| Net loss before taxes | -25,112 | -28,706 |
| Income tax expense | -182 | -73 |
| Net loss | -25,294 | -28,779 |
| Net loss per share - basic and diluted | -0.08 | -0.12 |
| Weighted-average shares outstanding - basic and diluted | 308,650 | 235,933 |
Income Statement
Three months ended March 31, — (In thousands) (in thousands)
| Three months ended March 31, – 2026 | Three months ended March 31, – 2025 | ||
|---|---|---|---|
| Reconciliation of Non-GAAP Gross Profit: | Gross profit | 363 | 39 |
| Reconciliation of Non-GAAP Gross Profit: | Inventory related write-downs | 27 | |
| Reconciliation of Non-GAAP Gross Profit: | Amortization of acquired intangibles | 217 | |
| Reconciliation of Non-GAAP Gross Profit: | Adjusted Gross Profit | 390 | 256 |
| Reconciliation of Non-GAAP Loss: | GAAP Net loss | -25,294 | -28,779 |
| Reconciliation of Non-GAAP Loss: | Interest expense, net | 2,666 | 12,615 |
| Reconciliation of Non-GAAP Loss: | Provision for income taxes | 182 | 73 |
| Reconciliation of Non-GAAP Loss: | Depreciation and amortization | 2,368 | 1,408 |
| Reconciliation of Non-GAAP Loss: | Unrealized gain on derivative liability | -3,380 | -842 |
| Reconciliation of Non-GAAP Loss: | Unrealized gain on warrant liability | -604 | -1,761 |
| Reconciliation of Non-GAAP Loss: | Loss on debt extinguishment | 3,083 | 4,654 |
| Reconciliation of Non-GAAP Loss: | Gain on disposal of fixed assets | -108 | |
| Reconciliation of Non-GAAP Loss: | Impairment of operating lease right-of-use assets | 9 | |
| Reconciliation of Non-GAAP Loss: | Share-based compensation expense | 983 | 1,921 |
| Reconciliation of Non-GAAP Loss: | Inventory related write-downs | 27 | |
| Reconciliation of Non-GAAP Loss: | Acquisition-related costs | 1,727 | |
| Reconciliation of Non-GAAP Loss: | Restructuring charges | 1,139 | |
| Reconciliation of Non-GAAP Loss: | Adjusted EBITDA | -17,202 | -10,711 |
Balance Sheet
December 31, — (In thousands) (in thousands)
| March 31, – 2026 | December 31, – 2025 | ||
|---|---|---|---|
| Current assets | Cash and cash equivalents | 46,120 | 32,363 |
| Current assets | Investment securities, available-for-sale | 42,471 | |
| Current assets | Restricted cash, current | 485 | 497 |
| Current assets | Accounts receivable, net of allowances | 732 | 47 |
| Current assets | Inventory | 4,028 | 745 |
| Current assets | Other current assets | 2,858 | 4,989 |
| Current assets | Total current assets | 54,223 | 81,112 |
| Current assets | Property and equipment, net | 17,300 | 4,280 |
| Current assets | Operating lease right-of-use assets | 17,929 | 14,075 |
| Current assets | Restricted cash, net of current portion | 1,189 | 1,204 |
| Current assets | Intangible assets, net | 13,662 | 32 |
| Current assets | Goodwill | 3,677 | |
| Current assets | Other assets | 2,224 | 2,416 |
| Current assets | Total assets | 110,204 | 103,119 |
| Current liabilities | Accounts payable | 4,537 | 1,628 |
| Current liabilities | Accrued liabilities | 7,542 | 5,426 |
| Current liabilities | Deferred revenue | 411 | |
| Current liabilities | Derivative liability | 2,035 | |
| Current liabilities | Notes payable | 32,141 | 19,212 |
| Current liabilities | Operating lease liabilities, current | 4,985 | 3,481 |
| Current liabilities | Finance lease liabilities, current | 13 | 14 |
| Current liabilities | Other current liabilities | 99 | 388 |
| Current liabilities | Total current liabilities | 51,763 | 30,149 |
| Current liabilities | Warrant liability | 1,271 | 1,875 |
| Current liabilities | Operating lease liabilities, net of current portion | 16,259 | 14,034 |
| Current liabilities | Finance lease liabilities, net of current portion | 21 | 27 |
| Current liabilities | Other long-term liabilities | 1,347 | 1,486 |
| Current liabilities | Total liabilities | 70,661 | 47,571 |
| Shareholders’ equity | Common stock at par value | 322 | 306 |
| Shareholders’ equity | Additional paid-in capital | 1,021,218 | 1,011,835 |
| Shareholders’ equity | Accumulated other comprehensive income | 559 | 669 |
| Shareholders’ equity | Accumulated deficit | -982,556 | -957,262 |
| Shareholders’ equity | Total shareholders’ equity | 39,543 | 55,548 |
| Shareholders’ equity | Total liabilities and shareholders’ equity | 110,204 | 103,119 |
Cash Flow
Three months ended March 31, — (In thousands) (in thousands)
| Three months ended March 31, – 2026 | Three months ended March 31, – 2025 | ||
|---|---|---|---|
| Cash flows from operating activities | Net loss | -25,294 | -28,779 |
| Adjustments to reconcile net loss to net cash used in operations: | Depreciation and amortization | 2,368 | 1,408 |
| Adjustments to reconcile net loss to net cash used in operations: | Unrealized gain on derivative liability | -3,380 | -842 |
| Adjustments to reconcile net loss to net cash used in operations: | Unrealized gain on warrant liability | -604 | -1,761 |
| Adjustments to reconcile net loss to net cash used in operations: | Loss on debt extinguishment | 3,083 | 4,654 |
| Adjustments to reconcile net loss to net cash used in operations: | Bargain purchase gain | -147 | |
| Adjustments to reconcile net loss to net cash used in operations: | Gain on disposal of fixed assets | -108 | |
| Adjustments to reconcile net loss to net cash used in operations: | Impairment of operating lease right-of-use assets | 9 | |
| Adjustments to reconcile net loss to net cash used in operations: | Inventory write-downs | 27 |
Full release
Certain statements contained in this release, including market position, expectations, and likelihood of success; opportunities for customer engagement and revenue; expense reduction; benefits of acquisitions and integration synergies; market position; product portfolio; product and manufacturing capabilities; transaction benefits; access to capital and capital-raising opportunities; and expected revenue, expenses and cash usage are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking statements include the risk its ability to operate with limited cash or to raise additional capital when needed; market acceptance of its technologies and products or for products incorporating its technologies; the failure of its commercial partners to perform as expected under its agreements; its financial and technical resources relative to those of its competitors; its ability to keep up with rapid technological change; government regulation of its technologies; its ability to enforce its intellectual property rights and protect its proprietary technologies; the ability to obtain customers and develop partnership opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market its products; potential product liability claims; its ability to maintain its listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company’s SEC reports, including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect the Company to a greater extent than indicated. Except as expressly required by federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.
Investor
Relations Contact
Jeff
Christensen
Darrow
Associates Investor Relations
MVIS@darrowir.com
Media
Contact
Marketing@MicroVision.com
Source:
MicroVision, Inc.
MicroVision,
Inc.
Consolidated
Balance Sheets
(In thousands)
MicroVision,
Inc.
Consolidated
Statement of Operations
(In thousands, except per share data)
MicroVision,
Inc.
Consolidated
Statements of Cash Flows
(In thousands)
The following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of March 31, 2026 and 2025:
MicroVision,
Inc.
Reconciliation of GAAP to Non-GAAP Measures
(In thousands)